THURSDAY, April 7, 2022 (HealthDay News) — A handful of former directors of the U.S. Centers for Disease Control and Prevention say they support a sweeping review of the agency that’s been ordered up by CDC head Dr. Rochelle Walensky. Earlier this week, Walensky announced that she has asked outsideContinue Reading
THURSDAY, April 7, 2022 (HealthDay News) — Urinary tract infections are common and usually simple to treat. But for people who become sick enough to land in the hospital with one, an experimental antibiotic may soon offer a new treatment option — taken by mouth instead of delivered by IV.Continue Reading
THURSDAY, April 7, 2022 (HealthDay News) – Outlining a daunting timeline for development of any updated coronavirus vaccine for next fall, federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin by next month, and a final formula chosen byContinue Reading
WEDNESDAY, April 6, 2022 (HealthDay News) — Humans and their pets tend to share a tight bond, but they may also share antibiotic-resistant bacteria, new research shows. Even worse for humans is the fact that these bacteria may contain antibiotic-resistant genes that can make the bacteria they already have inContinue Reading
WEDNESDAY, April 6, 2022 (HealthDay News) — An advisory panel to the U.S. Food and Drug Administration will meet Wednesday to discuss the best way forward with coronavirus vaccines, as evidence grows that variants are eroding the power of the country’s current shots. “As we prepare for future needs toContinue Reading
WEDNESDAY, April 6, 2022 (HealthDay News) — Israel’s government made a second booster dose of the Pfizer vaccine available to all of its citizens aged 60 and older at the beginning of this year. Now, emerging data suggests this fourth dose greatly boosts protection against the Omicron variant. In aContinue Reading
WEDNESDAY, April 6, 2022 (HealthDay News) — Vaccines did a good job protecting most cancer patients against COVID-19, but those with blood cancers remain at risk for breakthrough infections, new research suggests. The study analyzed nationwide data on more than 64,000 U.S. cancer patients who were vaccinated against SARS-CoV-2. TheContinue Reading
TUESDAY, April 5, 2022 (HealthDay News) — Public health experts have been telling pregnant women that it is safe — and recommended — to get a COVID-19 shot because they are at higher risk for poor outcomes and death from the virus. New research now answers a key question aboutContinue Reading
MONDAY, April 4, 2022 (HealthDay News) — Does youthful experimentation with drugs and alcohol always fade with age? Not necessarily, a long-term study warns. Researchers found that more than 60% of teens who report heavy use of alcohol, marijuana, and/or other drugs continue to have a drug problem as adults,Continue Reading
MONDAY, April 4, 2022 (HealthDay News) — Efforts to cut back on risky opioid use for pain after surgery are trickling down to kids. New research shows that fewer Americans under the age of 18 were prescribed narcotics to treat surgical pain between 2014 and 2017, and these numbers droppedContinue Reading
MONDAY, April 4, 2022 (HealthDay News) — Now that many Americans can get not one, but two booster shots, how do you know if they are right for you? Michigan Medicine-University of Michigan offers some advice based on updated findings and recommendations. “Everyone over age 12 should get a [first]Continue Reading
MONDAY, April 4, 2022 (HealthDay News) – People who live heart failure with reduced ejection fraction can now turn to a diabetes drug to help them feel better, stay out of the hospital and potentially live longer. Three leading heart organizations — the American College of Cardiology, American Heart AssociationContinue Reading
FRIDAY, April 1, 2022 (HealthDay News) — If you’ve had COVID-19 but not your COVID shot, you may wonder if getting a vaccine now will really help you. It will, two new studies say. Researchers in Brazil and Sweden confirmed that COVID-19 vaccines provided significant additional protection for people whoContinue Reading
THURSDAY, March 31, 2022 (HealthDay News) — In a close vote, an advisory panel for the U.S. Food and Drug Administration decided not to recommend the approval of an experimental drug for the deadly neurological disease amyotrophic lateral sclerosis (ALS). The panel’s decision had been closely watched, with patient advocacyContinue Reading